Streetbeat News

Stock Prices

AMD

APO

INTC

QCOM

Intel and AMD are in a competitive race against Nvidia in the semiconductor industry. Intel is facing challenges with a significant stock decline but potential investments from Apollo and acquisition talks with Qualcomm could signal a turnaround. AMD, on the other hand, has seen a stock surge due to its AI-driven growth, but recent volatility raises concerns. Intel offers a speculative high-risk, high-reward opportunity, while AMD presents a more stable investment with strong fundamentals.

Portfolio Pulse from Surbhi Jain

September 25, 2024 | 12:25 pm

GLMD

Galmed Pharmaceuticals has published the one-year results of its Phase 3 trial of Aramchol, showing significant anti-fibrotic effects in patients with NASH and fibrosis. The study, involving 150 patients, was published in Hepatology.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 12:21 pm

KBH

KB Home shares declined after Q3 earnings despite beating EPS and revenue estimates. The company reported flat net orders compared to last year and noted a softening in demand from late June through July.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 12:19 pm

SEEL

Seelos Therapeutics shares are trading higher following the announcement of a 1-for-16 reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 12:18 pm

SEEL

Seelos Therapeutics announced a 1-for-16 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement. The split will be effective on September 27, 2024, and the stock will trade under the same symbol 'SEEL' with a new CUSIP number.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 12:18 pm

PCRX

DOMA Perpetual Capital Management has urged Pacira Biosciences to accelerate and increase its share buyback program, citing the company's $400 million cash balance as inefficient. They believe the current stock price presents an opportunity for significant shareholder returns.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 12:17 pm

BABA

GVIP

JTEK

LI

NVDA

XPEV

Alibaba's Apsara Conference showcased AI advancements with participation from Nvidia and XPeng. Despite US sanctions, Alibaba continues to push its AI initiatives and partnerships, including with XPeng and Nvidia. Alibaba's stock has risen over 11% in the past year.

Portfolio Pulse from Anusuya Lahiri

September 25, 2024 | 12:16 pm

WINT

Windtree Therapeutics announced positive topline results from its Phase 2B SEISMiC extension study of Istaroxime in early cardiogenic shock. The study showed significant improvements in systolic blood pressure over six hours and notable secondary endpoint improvements.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 12:10 pm

AVDL

Avadel Pharmaceuticals published data in 'Sleep Medicine' showing the efficacy of LUMRYZ in improving narcolepsy symptoms, regardless of alerting agent use. The Phase 3 REST-ON trial confirmed significant improvements in wakefulness and reduced cataplexy episodes.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 12:10 pm

ERAS

Erasca, Inc. (NASDAQ:ERAS) will present preliminary Phase 1 data for naporafenib plus trametinib in RAS Q61X mutant solid tumors at the 36th EORTC-NCI-AACR Symposium. The company is also conducting a Phase 3 trial in NRAS-mutant melanoma. A virtual R&D update for investors is scheduled for October 24, 2024.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 12:09 pm